首页> 外文会议>International Molecular Medicine Tri-Conference. >Identification of Circulating Pluripotent Cancer Stem Cells in the Blood of Prostate Cancer Patients for the Diagnosis of Metastatic Cancer
【24h】

Identification of Circulating Pluripotent Cancer Stem Cells in the Blood of Prostate Cancer Patients for the Diagnosis of Metastatic Cancer

机译:鉴定前列腺癌患者血液中循环多能癌症干细胞诊断转移性癌症

获取原文

摘要

Over 90% of all cancer related deaths are due to metastasis. However, current existing cancer markers and diagnostic tools are not able to distinguish between invasive and localized cancers. In order to achieve meaningful progress in cancer treatment, new early stage technologies and biomarkers that accurately diagnose life-threatening disease are needed. This project is driven by the hypothesis that metastatic cancers are driven by embryonic/pluripotent cancer stem cells defined by TRA-1-60 (TRA) expression, an embryonic stem cell marker.
机译:超过90%的癌症相关死亡是由于转移。然而,目前现有的癌症标记和诊断工具不能区分侵入性和局部癌症。为了实现癌症治疗的有意义进展,需要准确诊断危及危及生命疾病的新早期技术和生物标志物。该项目由假设驱动,即转移性癌症由由TRA-1-60(TRA)表达,胚胎干细胞标记物定义的胚胎/多能癌干细胞驱动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号